E-cadherin and β-catenin expression patterns in malignant melanoma assessed by image analysis

Journal of Cutaneous Pathology

Volumn 34, Issue 3, 2007, Pages 239-246

  Pećina Šlaus, Nives ^a   Žigmund, Martina ^a   Kušec, Vesna ^b   Martić, Tamara Nikuševa ^a   Čačić, Mirjana ^c   Šlaus, Mario ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Clinical Institute of Laboratory Diagnosis   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MOLECULAR MARKER; UVOMORULIN; WNT PROTEIN;

ADULT; AGED; ARTICLE; CANCER TISSUE; CELL JUNCTION; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DENSITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIGHT; MALE; MELANOMA; PERMEABILITY; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SKIN; STAINING;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CADHERINS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; MIDDLE AGED; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846913663     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00601.x     Document Type: Article

References (22)

1. Berx G, Staes K, van Hengel J et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995; 26: 281.
2. Gumbiner BM. Regulation of cadherin adhesive activity. J Cell Biol 2000; 14: 399.
3. Guilford P. E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today 1999; 5: 172.
4. Peina-Šlaus N. E-cadherin in normal and tumor cells. Cancer Cell Int 2003; E3:17 (available at http://www.cancerci.com/content/3/1/17).
5. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989; 8: 1711.
6. Kraus C, Liehr T, Hulsken J et al. Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics 1994; 23: 272.
7. Peifer M, Polakis P. Wnt signaling in Oncogenesis and Embriogenesis - a look outside the nucleus. Science 2000; 287: 1606.
8. Daniels DL, Weis WI. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol 2005; 12: 364.
9. He TC, Sparks AB, daCosta LT et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509.
10. Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nature Rev 2003; 3: 559.
11. Polsky D, Cordon-Cardo C. Oncogenes in melanoma. Oncogene 2003; 22: 3087.
12. Zuo L, Weger J, Yang Q et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nature Genet 1996; 12: 97.
13. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159.
14. Li G, Fukunaga M, Herlyn M. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling. Exp Cell Res 2004; 297: 142.
15. Clark HW. Clinical diagnosis of cutaneus malignant melanoma. JAMA 1978; 236: 484.
16. Krengel S, Groteluschen F, Bartsch S, Tronnier M. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. J Cutan Pathol 2004; 31: 1.
17. Jamal S, Schneider RJ. UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J Clin Invest 2002; 4: 443.
18. Chiles MC, Ai L, Zuo C, Fan CY, Smaller BR. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions. Mol Pathol 2003; 16: 1014.
19. Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 1999; 154: 325.
20. Hsu MY, Meier FE, Nesbit M et al. E- cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 2000; 156: 1515.
21. Mælandsmo GM, Holm R, Nesland JM, Fodstad O, Florenes VA. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin Cancer Res 2003; 9: 3383.
22. Kageshita T, Hamby CV, Ishihara T et al. Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 2001; 145: 210.